Literature DB >> 35771829

Novel RNA viruses associated with avian haemosporidian parasites.

Jose Roberto Rodrigues1, Scott W Roy1, Ravinder N M Sehgal1.   

Abstract

Avian haemosporidian parasites can cause malaria-like symptoms in their hosts and have been implicated in the demise of some bird species. The newly described Matryoshka RNA viruses (MaRNAV1 and MaRNAV2) infect haemosporidian parasites that in turn infect their vertebrate hosts. MaRNAV2 was the first RNA virus discovered associated with parasites of the genus Leucocytozoon. By analyzing metatranscriptomes from the NCBI SRA database with local sequence alignment tools, we detected two novel RNA viruses; we describe them as MaRNAV3 associated with Leucocytozoon and MaRNAV4 associated with Parahaemoproteus. MaRNAV3 had ~59% amino acid identity to the RNA-dependent RNA-polymerase (RdRp) of MaRNAV1 and ~63% amino acid identity to MaRNAV2. MaRNAV4 had ~44% amino acid identity to MaRNAV1 and ~47% amino acid identity to MaRNAV2. These findings lead us to hypothesize that MaRNAV_like viruses are widespread and tightly associated with the order Haemosporida since they have been described in human Plasmodium vivax, and now two genera of avian haemosporidians.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35771829      PMCID: PMC9246168          DOI: 10.1371/journal.pone.0269881

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

Avian haemosporidian parasites are found worldwide and over 1,500 different lineages have been described [1]. These parasites fall under the phylum Apicomplexa and include the genera Plasmodium, Leucocytozoon, and Haemoproteus [2]. Although all these parasites have different life cycles and vectors, they can cause malaria-like symptoms in the avian hosts. Species of avian haemosporidian parasites have been shown to exhibit variation in how they affect the host, with some cases being barely detectable and others resulting in severe anemia and death [3-5]. Naive avian communities have been found to be especially susceptible to haemosporidian infections, such as those in Hawaii where the introduction of Plasmodium relictum played a role in the extinction of native birds [6, 7]. Even though these parasites are prevalent worldwide and cause extinction-level threats to naive birds, not much is known about the viruses that potentially infect these parasites. Protists consist of a diverse umbrella of unicellular eukaryotic lineages including amoebas, phytoplankton’s, Leishmania, and Plasmodium parasites [8, 9]. The most recent common ancestor between protists and multicellular eukaryotes was likely part of the origin of eukaryotes [10]. This creates an interest in studying the RNA viruses of protists as it may provide information on the common ancestors of RNA viruses today [9]. Since it is believed that protists constitute all major eukaryotic lineages (supergroups) that diverged from the last common eukaryotic ancestor, it is possible that the direct predecessors of modern protists were present when the ancestors of multicellular eukaryotic viruses emerged [9]. Furthermore, many protists have remained in aquatic environments which suggests that they have evolved accompanied by their viromes. Aquatic environments can allow for virus survival through protection from UV radiation and desiccation. Taking into account all these evolutionary factors, it can be implied that protists are host to some of the most ancient RNA viruses that infect eukaryotes [9, 10]. In 2020, metatranscriptomic studies of human malaria parasites revealed the presence of an RNA virus that is suspected to infect the human malaria parasite, P. vivax. This RNA virus was named Matryoshka RNA virus 1 (MaRNAV1) and was only found in blood metatranscriptomes that were also infected with Plasmodium vivax [11]. The Russian term, Matryoshka, or “Russian doll” refers to how the RNA virus infects a parasite that in turn infects a vertebrate host. To assign the host of MaRNAV1, Charon et al. (2020) followed four assumptions: (i) high viral loads should only occur when the host parasite is also found in high amounts, (ii) the host parasite must be present when the virus is found, (iii) the virus has to be phylogenetically related to other previously identified viruses that infect similar parasite taxa, (iv) codon usage analysis should show similar results between the virus and its suspected host. In the same study, researchers used the RNA-dependent RNA-polymerase (the most conserved protein found in all RNA viruses) of MaRNAV1 to screen transcriptomes of avian samples infected with Leucocytozoon parasites, leading to the discovery of a second novel RNA virus named MaRNAV2 [11]. When the sequences for both of these viruses were aligned against the entire non-redundant protein database, the closest relatives were found to be RdRps of the Narnaviridae family. Viruses from this family are among the simplest biological entities and will often consist of only an RdRp as part of their genome [12]. Previously, narnaviruses have been discovered in arthropods, mosquitoes, fungi, and other protists [13]. The Wilkie narnalike virus 1 had the RdRp with highest amino acid similarity to MaRNAV1 and V2. The Wilkie narnalke virus 1 was isolated from mosquito metatranscriptomes, but researchers suspected that it likely infected a parasite in the mosquito and not the mosquito itself [14, 15]. Little is known about the effects of viruses that infect intracellular eukaryotic parasites. In another system, researchers examined the possible effects that Leishmania RNA virus 1 (LRV1) could have on Leishmania parasites. They found that the presence of the RNA virus enhances the pathogenicity of leishmaniasis in the vertebrate host [16]. These results show the importance of studying the interactions between RNA viruses and their single-celled hosts. Identifying these viruses in avian blood parasites could provide an ideal study system since birds and these parasites are found in natural ecosystems worldwide. Our objective here was to use available avian blood RNA data from the NCBI SRA database to search for the presence of RNA viruses associated with haemosporidian parasites. We identified two novel RNA viruses, one in Leucocytozoon infected birds and one in an individual infected with Haemoproteus (Parahaemoproteus). These findings expand the number of the Matryoshka viruses to include all three of the major haemosporidian host genera.

Methods

Using bioinformatic tools (Trinity, Trimmomatic, Diamond BLASTx), we performed local sequence alignments on the metatranscriptomes against the RdRps of RNA viruses of interest, including MaRNV1 and MaRNV2, which are suspected to infect Plasmodium and Leucocytozoon parasites, respectively. The raw SRA datasets used in this study were from blood samples of 24 birds captured and sampled across three locations in North America including: Alaska, New Mexico, and New York [17]. All 24 birds were previously confirmed positive for Plasmodium, Leucocytozoon, and/or Haemoproteus (Parahaemoproteus) parasites by metatranscriptomic analysis [18]. We also searched for RNA viruses in nine avian blood samples available on the NCBI SRA database that consisted of avian blood samples infected with P. ashfordi, P. delichoni, P. homocircumflexum, and Leucocytozoon parasites [19-21].

Transcriptome assembly

Raw sequence reads of 33 avian blood samples were downloaded from NCBI SRA by using fastq-dump to obtain in fastq format. Transcriptome assembly and quality trimming of the raw RNA reads were done by using Trinity Software v2.10.0 with Trimmomatic v0.40, using default parameters.

Virus discovery

A local sequence-based homology search was implemented using Diamond v0.9.24 BLASTx against protein databases that contained RNA-dependent RNA polymerases (RdRp) of interest. All RdRp protein sequences used in this study were downloaded from the NCBI protein database using accession codes. Each assembled transcriptome was searched using Diamond BLASTx against a database containing the RdRp sequences and other segments from the newly discovered Matryoshka RNA virus 1 (MaRNAV1) and Matryoshka RNA virus 2 (MaRNAV2) [11]. These same transcriptomes were then searched using Diamond BLASTx against all available RdRp sequences from NCBI in order to screen for the presence of any similar RNA viruses that may have been present. For each candidate hit identified, we performed a NCBI BLASTx search against the entire non-redundant protein database to find similar sequences. To further decrease the likelihood of the suspected RdRp proteins from being EVEs (viral elements integrated into the host genome), we performed an NCBI BLASTn search and found no evidence of them being EVEs. As controls, we used four P.vivax transcriptomes from Charon et al. (2020). Of these four, three were infected with MaRNAV1 and one was free of infection from either the parasite or the virus. All three positive control transcriptomes resulted in hits of MaRNAV1 at ~98% identity, while the negative control transcriptome resulted in no hits of MaRNAV1. Amino acid sequences were determined using NCBI ORF finder which translated nucleotide sequences in all six frames to determine open reading frames (ORF). NCBI ORF finder was used under parameters: minimum ORF length of 75 nucleotides (nt), genetic code standard, and using the ORF start codon of “ATG” only. The longest ORFs for MaRNAV3 and 4 were used for future analysis. Amino acid sequences of MaRNAV3 and 4 were submitted to the Protein Homology/Analogy Recognition Engine v 2.0 (Phyre2) web portal for structural-based homology searches and 3D structure prediction [22]. Both MaRNAV3 and 4 were submitted into the InterPro database for functional analysis by family classification and domain prediction [23].

Phylogenetic analysis

To further analyze the suspected RNA viruses discovered, we produced a phylogenetic tree encompassing all the virus RdRp sequences that were included in the study conducted by Charon et al. (2020) and added our candidate RdRp sequences. First, we retrieved sequences of RdRps from the NCBI database using the NCBI accession codes included in the phylogenetic tree that was produced by Charon et al. (2020). Downloaded sequences were then aligned using MAFFT v7.309 with the E-INS-I algorithm. The aligned sequences were then reformatted into Phylip|Phylip4 format so that they could be input into IQ-TREE for correct model selection [24]. The phylogenetic tree was outputted in Newick format. To view the phylogenetic tree, we used ggtree (R) and other R packages (ggplot2, treeio).

Results

We studied 33 avian blood metatranscriptomes infected with Plasmodium, Leucocytozoon, and Haemoproteus (Parahaemoproteus). From these metatranscriptomes we found three with the presence of novel Matryoshka RNA viruses (Table 1). The first, found in a bird infected with Leucocytozoon, we named MaRNAV3, which had 59.5% amino acid identity to MaRNAV1 and 63.0% amino acid identity to MaRNAV2. The second virus, which we named MaRNAV4, had 44.7% amino acid identity to MaRNAV1 and 47.0% amino acid identity to MaRNAV2 (Table 1). To our knowledge, MaRNAV4 is the first known virus to be associated with the genus Haemoproteus. This also makes MaRNAV3 & V4 only the third and fourth viruses discovered to be associated with the parasites of the Apicomplexa subclass haemosporidia.
Table 1

Data on specific hits of interest found in the 33 avian blood samples.

SRR8792714 & SRR8792718 hits had > 98% similarity, so we decided to use the longest ORF to represent as a single viral RdRp.

Hits to Viral RdRps from NCBI SRA dataset
Name/ SRA numberMaRNAV4 SRR8792714MaRNAV4 SRR8792718MaRNAV3 SRR8792722
Host Bird Species Vireo plumbeus Vireo plumbeus Acanthis flammea
Parasite(s) Present Parahaemoproteus Parahaemoproteus Leucocytozoon
Length of nt Sequence 3083 nt2864 nt3257 nt
Percent Identity to Matryoshka RdRps (%) 37–44%42–47%42–63%
Diamond BLASTx hits to RdRp Hits for MaRNAV1, MaRNAV2, and Wilkie-narna-like Virus 1 RdRpsHits for MaRNAV1, MaRNAV2, and Wilkie-narna-like Virus 1 RdRpsHits for MaRNAV1(59.5%), MaRNAV2 (63%), and Wilkie-narna-like Virus 1 (42.2%) RdRps
Longest ORF 977 aa938 aa994 aa
InterPro Results (short names) NoneNoneDNA/RNA_pol_sf,
Phyre2 Results 18% modeled with >90% confidence for DNA/RNA polymerases18% modeled with >90% confidence for DNA/RNA polymerases27% modeled with >90% confidence for DNA/RNA polymerase

Data on specific hits of interest found in the 33 avian blood samples.

SRR8792714 & SRR8792718 hits had > 98% similarity, so we decided to use the longest ORF to represent as a single viral RdRp. MaRNAV3 was discovered in a sample from an individual Alaskan songbird, Common redpoll (Acanthis flammea), that was infected with Leucocytozoon parasites [18]. The longest ORF identified was 994 AA in length and had 59.5% and 63.0% identity to MaRNAV1 and V2, respectively. When the longest ORF was input into InterPro for protein classification, it resulted in a match for DNA/RNA polymerase superfamily (IPR043502), which includes RdRps. When the longest ORF was run through Phyre2 in intensive mode for structure and function prediction, we had results for DNA/RNA polymerase superfamily with 27% modeled at >90% confidence (Table 1). In the same bird sample, we found positive hits for a second ORF that was 298 AA in length. The function of this ORF is unknown; however, it did have significant similarity to the second segments of MaRNAV1 and V2. This was another indication that MaRNAV3 is related to MaRNAV1 and V2 (S1 Table in S1 File). MaRNAV4 was found in two birds of the same species found in New Mexico (Plumbeous vireo (Vireo plumbeus)) that were infected with Parahaemoproteus parasites. The longest ORF associated with this virus is 977 AA in length and was 37–44%, identical to the RdRp sequences of MaRNAV1 and V2 (Table 1). For this suspected RdRp, we acquired no hits to any family domain when submitted into the InterPro database for analysis. The AA sequence was put through Phyre2 in intensive mode for structure and function prediction; we had results for DNA/RNA polymerase with 18% modeled at >90% confidence (Table 1). The longest ORF was also put into NCBI BLASTp against the entire non-redundant protein database. The proteins with the highest similarity to MaRNAV4 were narnaviruses that were associated with protists or arthropods (Fig 1), which strongly suggest that this was in fact a virus infecting Parahaemoproteus parasites, and not the vertebrate host. For MaRNAV4 we did not find the presence of any ORFs related to the second segments of MaRNAV1 and V2.
Fig 1

Phylogeny of possible RNA viruses associated with avian haemosporidian parasites.

Phylogenetic tree comparing the most closely related RdRps of MaRNAV3 and MaRNAV4 from the NCBI non-redundant protein database. The images on the right side are the expected host or environments where RNA viruses were discovered (Icons from BioRender.com). Sequences were aligned using the E-INS-I algorithm in MAFFT v7.309. Aligned sequences were put into IQ-tree v1.6.10, which chose the LG+F+I+G4 model according to BIC. The scale refers to the number of nucleotide substitutions per codon site, and the tree is unrooted although the taxon Grapevine associated narnavirus is drawn at the root. Created with BioRender.com.

Phylogeny of possible RNA viruses associated with avian haemosporidian parasites.

Phylogenetic tree comparing the most closely related RdRps of MaRNAV3 and MaRNAV4 from the NCBI non-redundant protein database. The images on the right side are the expected host or environments where RNA viruses were discovered (Icons from BioRender.com). Sequences were aligned using the E-INS-I algorithm in MAFFT v7.309. Aligned sequences were put into IQ-tree v1.6.10, which chose the LG+F+I+G4 model according to BIC. The scale refers to the number of nucleotide substitutions per codon site, and the tree is unrooted although the taxon Grapevine associated narnavirus is drawn at the root. Created with BioRender.com. To further investigate the newly discovered viral sequences, we performed phylogenetic analysis that included the two novel RNA viruses described here. In addition, we included MaRNAV1, MaRNAV2 and all of their other closest relatives identified through BLASTp against the entire non-redundant NCBI protein database. Phylogenetic analysis confirmed that MaRNAV3 and MaRNAV4 were closely related to the other Matryoshka RNA viruses, and that they belong in their own clade, separate from other narna-like viruses (Fig 1).

Discussion

We have identified two new members of the Matryoshka viruses that appear to infect the avian haemosporidian genera Haemoproteus and Leucocytozoon. The segment found for both MaRNAV3 and MaRNAV4 was a single ORF that consisted of a conserved RdRp-motif related to the motifs found in Narnaviridae, including MaRNAV1 and MaRNAV2. The Narnaviridae family consists of capsid-less viruses that have been suspected to infect plants, fungi, and protists [13]. We suspect that MaRNAV3 and MaRNAV4 have avian haemosporidian hosts because of their close relationship to other viruses associated with haemosporidians (Fig 1). MaRNAV3 is most closely related to MaRNAV1 and MaRNAV2 (Fig 1), which is expected as it is associated with Leucocytozoon parasites, similar to MaRNAV2. MaRNAV4 is less related to MaRNAV1 and MaRNAV2 (Fig 1), which is also to be expected, as the suspected host is Parahaemoproteus. The two main reasons we believe that MaRNAV3 and MaRNAV4 infect haemosporidian parasites are: (i) MaRNAV3 and V4 fall in the same clade as both MaRNAV1 and V2, which have been only found in the presence of their respective haemosporidian hosts, (ii) NCBI Blastx of MaRNAV3 and V4 results in the top hits coming from RdRp sequences from narna-like viruses that were found in arthropod or protist environments. However, further experimental studies would be necessary to confirm that the hosts of these viruses are haemosporidian parasites, and not the bird or other organisms inside the bird. Our results suggest a relatively low prevalence of these viruses, as we were only successful in finding three samples with positive hits from 33 metatranscriptomes, 24 from North America, and nine from Europe and Russia for MaRNAV3 and MaRNAV4. However, they have been found at higher prevalence in samples from Australia (8/12 samples) where these viruses where identified using both transcriptome analysis and rt-PCR for confirmation [11]. Since RNA viruses are known to have high rates of mutations, it is unlikely that the viruses described diverged through co-speciation as we would expect the amino acid identity to be much lower than ~41–60% [17]. In the same vein, avian haemosporidia phylogenetic analysis has shown that avian Plasmodium parasites are more closely related to Haemoproteus, than Leucocytozoon parasites [25]. Their respective associated viruses instead show that Plasmodium and Leucocytozoon parasites are more closely related than Haemoproteus parasites (Fig 1). Our data support the hypothesis by Charon et al. (2019) that Matryoshka RNA viruses evolve through viral cross-species transmission events because their parasite host will use arthropods as a vector, which can harbor a large number of parasites and bacteria. The vectors of these parasites likely are essential to these viral cross-species transmission events, as insects will often interact with a large number of parasites and vertebrates, which allows for the possible transfer of genetic material during co-infection [11, 26]. The high mutation rates would also help explain why Matryoshka RNA viruses are so divergent even when they infect the same genus, as in the case of MaRNAV2 and MaRNAV3 where both are associated with Leucocytozoon parasites but only have 63.0% amino acid identity. The discovery of these Matryoshka viruses associated with parasites of the genera Leucocytozoon and Haemoproteus in North America supports the theory that they are widespread since previously MaRNAV2 had only been found in bird samples from Australia [11]. More data would be necessary to discern the time-scale and occurrence of viral cross-species events [11]. Even though Narnaviridae are relatively simple viruses containing a single segment encoding for their RdRp, they may be able to impact their hosts in complex ways. There are three possible effects of an RNA virus on parasite-host relationships. The first is hypervirulence, where a virus can increase the pathogenicity of the tandem virus-parasite on the host [27]. The second is hypovirulence, which refers to a decrease in the pathogenicity of the parasite on its host [27]. The third is that the viruses will use the parasite as a vector to enter the vertebrate host [27]. Noted examples of hypervirulence have been shown in the cases of the genera Leishmania, Trichomonas, and Cryptosporidium, where the presence of a virus increases the pathogenic effects of the parasite [27]. Previous studies have also identified instances where the removal of the virus has caused hypovirulent effects on the parasite, such as in Giardia where the presence of G. lamblia virus (GLV) caused growth arrest of the parasites [27]. Free-living amoebas will often come into contact with humans and thus be rendered parasitic, and since protists can harbor viruses, they can be viewed as vectors into human hosts. This has been seen in the case of adenoviruses (causative agents of diarrhea, pneumonia, and conjunctivitis), where free-living amoebas protected the virus from harsh environments and acted as carriers into the hosts [27]. We currently do not know how Matryoshka RNA viruses affect the parasite-host relationship of haemosporidian parasites. More experimental work should be done to define these relationships. Since we have only found evidence of these viruses using bioinformatics methods, it is difficult to make any assumptions about MaRNA viruses. If MaRNA viruses cause hypovirulence, they could be useful in the creation of anti-malaria therapeutics. Further investigation is necessary to understand the relationship of these possibly significant viruses for the treatment of haemosporidian infections. It will be important to continue to search for these Matryoshka-like viruses in birds so that we can further understand their prevalence and diversity. It is still unclear if these RNA viruses are associated with all haemosporidians in all birds or only a select few: presently they have only been found in birds infected with Leucocytozoon or Haemoproteus. We presume that avian Plasmodium species should also be infected. However, although the virus was found in human samples infected with P. vivax, they were not found associated with P. falciparum [11]. Electron microscopy has revealed virus-like particles in the avian parasite genera Leucocytozoon, Parahaemoproteus and Plasmodium [28]. It would be interesting to ascertain whether these crystalloid inclusions were actually examples of Matryoshka viruses. Future studies to learn more about the infection biology of these RNA viruses would require isolation of an infected parasite and inoculating a healthy bird to analyze the gene expression levels of the birds throughout infection. This would give us clues into what molecular mechanisms these MaRNA viruses use to infect their parasite hosts. At this point, we have found evidence of these RNA viruses in three haemosporidian families, which suggests that they are widespread in a variety of different parasites in various locations around the globe.

InterPro results for longest ORF of RdRp like sequence associated with Leucocytozoon.

Shows Homology to the DNA/RNA polymerase super family. (TIF) Click here for additional data file.

Percent identity matrix of MaRNA viruses.

We found that two samples had similar RdRp sequences (~98% amino acid identity), hence we described them both as MaRNAV4. (TIF) Click here for additional data file.

S1 and S2 Tables controls data and information on protein of unknown function associated with MaRNAV3.

Results from datasets used to test pipeline used in this study. Results of protein with unknown function including InterPro submission data. (PDF) Click here for additional data file.

Diamond BLASTx results, IQ-Tree files, MaRNAV3 V4 RdRp sequences, Phyre2 structure prediction pdb files, MaRNAV3 second segment data, and Matryoshka viruses alignment.

Results from diamond BLASTx using two databases provided, and an E-value cutoff of 1E-10. Includes Trinity assembly stats report for all transcriptomes used in this study. IQ-Tree files include Newick format tree file and aligned sequences used for analysis. (ZIP) Click here for additional data file. 12 Jan 2022
PONE-D-21-37085
Novel RNA viruses associated with avian haemosporidian parasites
PLOS ONE Dear Dr. Rodrigues, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses all the points raised during the review process. Please submit your revised manuscript by Feb 26 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Maria Andreína Pacheco, Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating in your Funding Statement: (RS This work was supported by the grant to RNMS, NIH 1SC3GM118210-01A. Ravinder Sehgal grants.nih.gov JRR This work was supported by the Genentech Foundation Scholarship of the SEO office at San Francisco State University Jose Roberto Rodrigues The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.) Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf." 3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 4. We note that Figure 1 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The overall design of the study is acceptable and can conduct to the conclusion that new MaRNAV-like signals are identified as narna-like viruses and very likely infect bird hosts. Nevertheless, I would recommend to the authors to be more careful with the virus/host relationship establishment because, as well explained in the Discussion part, this study and the previous one from Charon et al are both based on bioinformatic identification. The use of "confirm" l. 197 is thus not adapted. On the other hand, some Narnaviridae are not only "suspected" fungal viruses as indicated l. 217 but have been clearly and experimentally associated to host infection (especially in S. cerevisiae). Discussion of the identification of second segment is missing, as well as the discussion of the potential presence of the virus in the host genome. I would recommend to the authors to conduct a Blastn of their newly identified sequences to the nt NCBI to ensure the newly identified viruses are not EVEs, i.e. viral elements integrated into host genomes. Please see below for minor comments/corrections : l.25 : Precise the taxon of parasites here ? (Apicomplexa/Haemosporidian) l.29 : Does it mean MaRNAV-3 share 40% with MaRNAV-1 and MaRNAV3 share 60% with MaRNAV-2 ? Unclear... l.56 : I would add another ref for the protist definition and phylogeny... Perhaps Burki F. et al. (2020) ‘The New Tree of Eukaryotes’, Trends in Ecology & Evolution, 35: 43–55. l.76 : RdRp cannot be considered as "highly" conserved but constitutes the most conserved protein in RNA viruses. l.83 : Narnaviruses have been previously identified in protists (Oomycetes and Leishmania). l.141: Indicate the parameters of ORF Finder (which genetic codes have been used for example). it can be critical when searching for protist viruses related to Lenarviricota as some could be mitochondria-associated. l.161 : I would not use the the term "infection" but rather "presence", "association". As detailed in the Discussion part, bioinfo-based virus identification do not formally demonstrate host infection... l.184 : What is the level of ID shared between the second segments of MaRNAV1 and 2 ? S2 table mention only one percentage for both MaRNAV1 and 2... No additional segments could be found for MaRNAV4 ? l.197 : Replace "confirm" by "strongly suggest" ? l.252 : The study in Charon et al has screened several SRA files from P. vivax Bioprojects to conclude that MaRNAV1 is widespread in P. vivax samples worldwide (not only in Malaysian samples). Table1 : Percent of identity with what ? Figure1: The quality is bad. Is the tree rooted ? What is the scale at the bottom ? Supplemental material : I would suggest sharing the alignment in fasta format. Could you share the Phyre2 info tables as well ? Reviewer #2: This is an interesting report. Perhaps the discussion is a little speculative, but I understand the need of providing a general context of otherwise a descriptive study. Some minor changes The phrase: “Even though protists are no less evolved than more complex multicellular eukaryotes, they play an important role in deducing the origins of RNA viruses today” I understand the intention, but even mentioning a “scala naturae” to dismiss it without arguing against do not assist the reader without background in evolutionary biology. This is not the place to discuss it, but it is not simply a stylistic matter so I found such a phrase a little unsettling. The issue could be addressed by simply stating that the most recent common ancestor between protists and multicellular eukaryotes likely was part of the origin of eukaryotes and as such, study the RNA viruses in the extant lineages of protist and multicellular eukaryotes may inform about the common ancestor of the RNA viruses observed today. Lines between 255-275 are too speculative, I suggest changing it by emphasizing, briefly, the need of experimental work to establish the viruses effect, if any, in their hosts (in this case the Haemosporida parasites). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
24 Mar 2022 Rebu Submitted filename: Response_to_reviewers.docx Click here for additional data file. 30 May 2022 Novel RNA viruses associated with avian haemosporidian parasites PONE-D-21-37085R1 Dear Dr. Rodrigues, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Maria Andreína Pacheco, Ph.D. Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: There are still a typos in the first page. I do not understand the use of the statement "These authors contributed equally to this work" and only appears one, which happen to be the corresponding. Perhaps it was intended for the other two authors. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No 22 Jun 2022 PONE-D-21-37085R1 Novel RNA viruses associated with avian haemosporidian parasites. Dear Dr. Rodrigues: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Maria Andreína Pacheco Academic Editor PLOS ONE
  25 in total

1.  The transcriptome of the avian malaria parasite Plasmodium ashfordi displays host-specific gene expression.

Authors:  Elin Videvall; Charlie K Cornwallis; Dag Ahrén; Vaidas Palinauskas; Gediminas Valkiūnas; Olof Hellgren
Journal:  Mol Ecol       Date:  2017-04-08       Impact factor: 6.185

Review 2.  Ecology and conservation biology of avian malaria.

Authors:  Dennis A Lapointe; Carter T Atkinson; Michael D Samuel
Journal:  Ann N Y Acad Sci       Date:  2012-02-09       Impact factor: 5.691

Review 3.  Rates of evolutionary change in viruses: patterns and determinants.

Authors:  Siobain Duffy; Laura A Shackelton; Edward C Holmes
Journal:  Nat Rev Genet       Date:  2008-03-04       Impact factor: 53.242

4.  Crystalloid inclusions in species of Leucocytozoon, Parahaemoproteus, and Plasmodium.

Authors:  W D Trefiak; S S Desser
Journal:  J Protozool       Date:  1973-02

Review 5.  The family narnaviridae: simplest of RNA viruses.

Authors:  Bradley I Hillman; Guohong Cai
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

6.  Metatranscriptomics yields new genomic resources and sensitive detection of infections for diverse blood parasites.

Authors:  Spencer C Galen; Janus Borner; Jessie L Williamson; Christopher C Witt; Susan L Perkins
Journal:  Mol Ecol Resour       Date:  2019-12-13       Impact factor: 7.090

7.  The Phyre2 web portal for protein modeling, prediction and analysis.

Authors:  Lawrence A Kelley; Stefans Mezulis; Christopher M Yates; Mark N Wass; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2015-05-07       Impact factor: 13.491

8.  De novo assembly of the dual transcriptomes of a polymorphic raptor species and its malarial parasite.

Authors:  Martina Pauli; Nayden Chakarov; Oliver Rupp; Jörn Kalinowski; Alexander Goesmann; Michael D Sorenson; Oliver Krüger; Joseph Ivan Hoffman
Journal:  BMC Genomics       Date:  2015-12-09       Impact factor: 3.969

9.  Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition.

Authors:  Renan V H de Carvalho; Djalma S Lima-Junior; Marcus Vinícius G da Silva; Marisa Dilucca; Tamara S Rodrigues; Catarina V Horta; Alexandre L N Silva; Patrick F da Silva; Fabiani G Frantz; Lucas B Lorenzon; Marcos Michel Souza; Fausto Almeida; Lilian M Cantanhêde; Ricardo de Godoi M Ferreira; Angela K Cruz; Dario S Zamboni
Journal:  Nat Commun       Date:  2019-11-21       Impact factor: 14.919

10.  The InterPro protein families and domains database: 20 years on.

Authors:  Matthias Blum; Hsin-Yu Chang; Sara Chuguransky; Tiago Grego; Swaathi Kandasaamy; Alex Mitchell; Gift Nuka; Typhaine Paysan-Lafosse; Matloob Qureshi; Shriya Raj; Lorna Richardson; Gustavo A Salazar; Lowri Williams; Peer Bork; Alan Bridge; Julian Gough; Daniel H Haft; Ivica Letunic; Aron Marchler-Bauer; Huaiyu Mi; Darren A Natale; Marco Necci; Christine A Orengo; Arun P Pandurangan; Catherine Rivoire; Christian J A Sigrist; Ian Sillitoe; Narmada Thanki; Paul D Thomas; Silvio C E Tosatto; Cathy H Wu; Alex Bateman; Robert D Finn
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.